Jazz Pharmaceuticals
JAZZ
#1955
Rank
S$13.39 B
Marketcap
S$220.40
Share price
0.20%
Change (1 day)
30.82%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: S$13.39 Billion

As of January 2026 Jazz Pharmaceuticals has a market cap of S$13.39 Billion. This makes Jazz Pharmaceuticals the world's 1955th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$13.39 B0.7%
2025S$13.30 B29.9%
2024S$10.23 B0.12%
2023S$10.22 B-23.95%
2022S$13.44 B27.02%
2021S$10.58 B-13.68%
2020S$12.26 B8.55%
2019S$11.29 B16.02%
2018S$9.73 B-9.8%
2017S$10.79 B14.24%
2016S$9.45 B-22.46%
2015S$12.18 B-7.09%
2014S$13.11 B41.42%
2013S$9.27 B145.56%
2012S$3.77 B79.13%
2011S$2.10 B108.2%
2010S$1.01 B192.96%
2009S$0.34 B410.27%
2008S$67.76 M-86.95%
2007S$0.51 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Jazz Pharmaceuticals was reported to be:

S$13.36 Billion
by Nasdaq info icon info icon
S$13.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Endo International
ENDPQ
S$0.18 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
S$46.54 B 247.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$353.69 B 2,540.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
S$47.79 B 256.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel